WikiSWOT
  • Home|
  • About Us|
  • How it Works|
  • Free SWOTs|
  • What's a SWOT?|
  • FAQ|
Pharmaceuticals & Biotech >> Johnson & Johnson SWOT Analysis:
Strengths
  • Diversified product offerings: company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics
  • Company covers the almost the full spectrum of the supply chain (research and development, manufacture and sale of products)
  • Growing presence in oncology
  • Support from non-pharmaceutical business
     divisions
  • Significant sales and marketing capabilities

 BLAHH! SWAGG :)
 
 ***
 
 Weaknesses
[list]
 [*] Generic drug's exposure
 [*] Private label exposure
 [*] High reliance on sales of CNS and Risperdal
 [*] Expensives
 [*] Meteors
 [*] Raptors
Opportunities
  • Leverage experience with therapeutic proteins and monoclonal antibodies across
     other therapy areas
  • Integrate recent acquisitions (Conor Medsystems, Robert Reid, Maya's Mom)
  • Further acquisitions
  • Global expansion
Threats
  • Branding damage due to recalls
  • Healthcare regulations
  • Private label growth; generic drugs growth
  • Weaker consumer environment expected in the US
  • Spreading too thinly - made investments in non-core areas, like social media with Maya's Mom

History: Version 20 (Newest), Version 19, Version 18, Version 17, Version 16, Version 15, Version 14, Version 13, Version 12, Version 11, Version 10, Version 9, Version 8, Version 7, Version 6, Version 5, Version 4, Version 3, Version 2, Version 1 (Oldest)



Go back to the SWOT analysis index, or start a discussion about Johnson & Johnson SWOT analysis by adding a comment below WikiSWOT Comments


SR March 17, 2010
This is great!
 
Name
Email (not shared)
Website

Add comment